Rivulet Media Inc (fka RIVU)

[cvinvestor]

This is where I have been losing confidence. This was to be addressed in a timely fashion. We are over 4 months out from the date of this PR statement - 4 months without a drop of news - nada and the latest 10-Q showed no money spent on research. So what's going on? What is a timely fashion, a year, 5 years, 10 years. A drug which had a timeline of initiated clinical trials beginning a year ago has now disappeared - into silence - no clarity as to what the company is doing, what the problem was, whether or how it will be overcome. NADA.

Believe me, if there was a boatload of good news, we would have heard about it.

I fear I've been taken on an extended journey to no where.

This supports why safety issue will pass

"Given the HemaXellerate I(TM) product is derived from the patient's own fat tissue, and numerous key opinion leaders support clinical entry of our product, as demonstrated by our peer reviewed publication www.translational-medicine.com/content/pdf/1479-5876-10-231.pdf., we are confident the safety studies the FDA requested clarification on can be addressed in a timely fashion," stated Thomas Ichim, Regen's Chief Scientific Officer and Board Member.